CLAIM #3335 · Abbott Laboratories (ABT) · 2025Q4 earnings call · Jan 22, 2026 · due Dec 31, 2026
“Expect to do more of the same, focus on the things that are strategically aligned and adhere to where we continue to look at a 50 to 70 basis point improvement in operating margins every year, and that's kind of what we've got built into this and fully expect we'll do that through both gross margin expansion as we've done, but continue to gain leverage in the P&L where appropriate.”
Philip Boudreau · CFO
How to check this claim
Look at: Operating margin improvement (change in full-year operating margin, fiscal 2026 vs fiscal 2025)
It came true if: Operating margin increase of 50 to 70 basis points year-over-year
Where: Company income statement / annual report (10-K) or Q4 2026 earnings call operating margin disclosure
In context
“r second inning, but we're far away from being from the seventh inning on this one. So I think there's still a lot of opportunity here. We're in a good position. Robbie Marcus: Great. Maybe just a quick follow-up. It's great to see you're still able to do double-digit EPS growth in 2026. I would imagine that's coming through the top line and margin expansion. Should we think about the magnitude of margin expansion and the drivers of it? Philip Boudreau: Thank you. Yes. I'll let Bill take that. Philip Boudreau: Yeah. Thanks, Robbie. You know, I couldn't be more proud of what the team accomplished in 2025 as Robert outlined. You know, overcoming uncertainties, volatilities, and whatnot still drive margin expansion. And that commitment to the execution and excellence there maintains in 2026. Expect to do more of the same, focus on the things that are strategically aligned and adhere to where we continue to look at a 50 to 70 basis point improvement in operating margins every year, and that's kind of what we've got built into this and fully expect we'll do that through both gross margin expansion as we've done, but continue to gain leverage in the P&L where appropriate. So that's kind of how we've constructed that double-digit earnings. Appreciate it. Thank you very much. Thank you. Operator: Next question will come from Vijay Kumar from Evercore ISI. Vijay Kumar: Hi, Robert. Good morning, and thanks for taking my question. My first one on maybe on the product side. Aveir, like you mentioned, another double-digit quarter. Just curious on where are we from a penetration standpoint, what innings are we in? And you know, how durable is this double-digit growth in a category that's, you know, a pacemaker, low single-digit growth category, and you guys are doing double digits? Robert Ford: Sure. Well, I made some comments about, you know, we look at this rhythm management $10 billion market as actually an opportunity to grow. So we have been making our invest”
Verify independently
SEC filings for ABT ↗ · Claim quote is verbatim from the 2025Q4 earnings call.